BRIM Biotechnology, Inc. (TPE:6885)
Taiwan
· Delayed Price · Currency is TWD 21.85
-0.60 (-2.67%)
At close: May 13, 2025
BRIM Biotechnology Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Cash & Equivalents | 502.76 | 948 | 837.99 | 399.75 | 83.03 | Upgrade
|
| Short-Term Investments | 1,346 | 747.63 | - | 23.84 | 86.42 | Upgrade
|
| Cash & Short-Term Investments | 1,849 | 1,696 | 837.99 | 423.59 | 169.45 | Upgrade
|
| Cash Growth | 9.03% | 102.34% | 97.83% | 149.98% | -60.90% | Upgrade
|
| Other Receivables | 10.01 | 6.24 | 0.45 | 0.37 | 0.63 | Upgrade
|
| Receivables | 10.01 | 6.24 | 0.45 | 0.37 | 0.63 | Upgrade
|
| Prepaid Expenses | 17.43 | 11.1 | 10.55 | 6.65 | 6.16 | Upgrade
|
| Total Current Assets | 1,876 | 1,713 | 848.99 | 430.61 | 176.24 | Upgrade
|
| Property, Plant & Equipment | 11.79 | 6.37 | 7.99 | 3.62 | 6.39 | Upgrade
|
| Long-Term Investments | 38.27 | 57.3 | 82.33 | 60.35 | 134.07 | Upgrade
|
| Other Intangible Assets | 483.39 | 1.34 | 0.09 | - | - | Upgrade
|
| Other Long-Term Assets | 1.02 | 0.7 | 0.59 | 0.86 | 0.59 | Upgrade
|
| Total Assets | 2,411 | 1,779 | 939.99 | 495.44 | 317.28 | Upgrade
|
| Accrued Expenses | 15.52 | 36.04 | 16.99 | 12.34 | 44.99 | Upgrade
|
| Current Portion of Leases | 4.23 | 3.48 | 3.63 | 2.85 | 3.58 | Upgrade
|
| Current Unearned Revenue | - | - | - | - | 1.12 | Upgrade
|
| Other Current Liabilities | 331.08 | 2.52 | 1.87 | 2.05 | 1.14 | Upgrade
|
| Total Current Liabilities | 350.84 | 42.05 | 22.48 | 17.23 | 50.82 | Upgrade
|
| Long-Term Leases | 3.54 | 0.11 | 2.81 | 0.32 | 2.64 | Upgrade
|
| Total Liabilities | 354.38 | 42.16 | 25.3 | 17.55 | 53.46 | Upgrade
|
| Common Stock | 1,315 | 1,158 | 932.54 | 692.54 | 588.86 | Upgrade
|
| Additional Paid-In Capital | 1,435 | 1,555 | 589.72 | 454.31 | 232.36 | Upgrade
|
| Retained Earnings | -884.69 | -1,149 | -771.19 | -746.92 | -641.47 | Upgrade
|
| Comprehensive Income & Other | 191.41 | 173.56 | 163.63 | 77.96 | 84.07 | Upgrade
|
| Total Common Equity | 2,056 | 1,737 | 914.69 | 477.89 | 263.82 | Upgrade
|
| Shareholders' Equity | 2,056 | 1,737 | 914.69 | 477.89 | 263.82 | Upgrade
|
| Total Liabilities & Equity | 2,411 | 1,779 | 939.99 | 495.44 | 317.28 | Upgrade
|
| Total Debt | 7.78 | 3.59 | 6.44 | 3.16 | 6.22 | Upgrade
|
| Net Cash (Debt) | 1,841 | 1,692 | 831.55 | 420.42 | 163.23 | Upgrade
|
| Net Cash Growth | 8.80% | 103.48% | 97.79% | 157.57% | -62.08% | Upgrade
|
| Net Cash Per Share | 15.78 | 16.83 | 11.66 | 7.09 | 2.77 | Upgrade
|
| Filing Date Shares Outstanding | 131.5 | 115.75 | 93.25 | 69.25 | 58.89 | Upgrade
|
| Total Common Shares Outstanding | 131.5 | 115.75 | 93.25 | 69.25 | 58.89 | Upgrade
|
| Working Capital | 1,525 | 1,671 | 826.51 | 413.38 | 125.42 | Upgrade
|
| Book Value Per Share | 15.64 | 15.00 | 9.81 | 6.90 | 4.48 | Upgrade
|
| Tangible Book Value | 1,573 | 1,735 | 914.6 | 477.89 | 263.82 | Upgrade
|
| Tangible Book Value Per Share | 11.96 | 14.99 | 9.81 | 6.90 | 4.48 | Upgrade
|
| Machinery | 9.12 | 6.46 | 4.84 | 3.59 | 4.23 | Upgrade
|
| Leasehold Improvements | 3.67 | 3.44 | 3.19 | 3.07 | 3.07 | Upgrade
|
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.